ISB News

The Women of ISB: Phyliss Lee, Software Engineer

Name:

Phyliss Lee

Lab:

Shmulevich

Research:

I help create websites and pages for the Cancer Genomics Cloud Pilot Project. The tools that I’m building will not only help scientists gather petabytes of cancer genomic data faster, but will also help them run analyses and visualize the data graphically. What I’m building has the potential to reach millions of people.

Working at ISB:

What I like about being in science is that there are truly no stupid questions. Working at ISB has thrown me into the deep end of biology. I’d never taken a biology class in my life. But the scientists here are so passionate and are happy to talk to me about their research. I’m also so fortunate to work on a team that’s about 50-50 female developers, software engineers.

Advice for future software engineers:

I definitely encourage young girls to start coding. It not only helps you build cool things, but it also helps you think about everyday decisions in a more rational manner.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.